Back to Agenda
From Bedside to Bench to Bedside: How Adverse Events Converge Clinical Research and Clinical Care
Session Chair(s)
Allison Cuff Shimooka, MBA
Chief Operating Officer
TransCelerate Biopharma Inc, United States
This session explores adverse event collection, processing, and actioning fundamentals as critical for integrating patient safety within teams, organizations, and the broader clinical research and patient care ecosystems.
Learning Objective : Discuss improvements within the drug safety landscape to adverse event reporting, processing, decision-making, and communication; Appraise stakeholder roles in protecting patients and promoting public health; Discuss opportunities for adverse event stakeholders to collaborate across the health care continuum (clinical development, safety, advocacy).
Speaker(s)
Panelist
Rebecca Noss, MS
Noss Research Consulting, United States
President, Global Pharmacovigilance Consultant
Panelist
Narayan Nair, MD
FDA, United States
Associate Director Regulatory Affairs, Office of Biostatistics and Pharmacovigil
Panelist
Jeremy Jokinen, PHD, MS
Argenx, United States
Vice President and Head Global Patient Safety
Have an account?